Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
2010

Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent

Sample size: 1 publication Evidence: low

Author Information

Author(s): Jessica Yeates, Mohsin Rashid

Primary Institution: Dalhousie University, IWK Health Centre

Hypothesis

Can infliximab effectively treat chronic refractory pouchitis in adolescents?

Conclusion

Infliximab is a safe and effective therapy for refractory pouchitis in adolescents, maintaining long-term remission.

Supporting Evidence

  • The patient had severe ulcerative pancolitis and underwent colectomy and IPAA.
  • After failing multiple treatments, infliximab was administered and resulted in immediate symptom relief.
  • The patient remained in complete remission for 36 months after starting infliximab.

Takeaway

This study shows that a medicine called infliximab can help kids with a tough tummy problem called pouchitis feel better and stay healthy for a long time.

Methodology

Case report of an adolescent treated with infliximab for chronic refractory pouchitis after colectomy and IPAA.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

An adolescent female with a history of severe ulcerative colitis and pouchitis.

Digital Object Identifier (DOI)

10.1155/2010/860394

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication